
Ed Gillis travels to advance Vasalgel
Ed Gillis, CEO of Revolution Contraceptives, the social venture company tasked with developing Vasalgel for Parsemus Foundation, traveled to Paris this spring to exchange ideas
Ed Gillis, CEO of Revolution Contraceptives, the social venture company tasked with developing Vasalgel for Parsemus Foundation, traveled to Paris this spring to exchange ideas
We regularly hear that obesity is a risk factor for various diseases, and we’re beginning to understand that some diseases have overlapping risk factors and
High levels of vitamin D have been related to lower levels of breast cancer, report scientists from the University of California San Diego. Expanding on
Results of the TAILORx clinical study may change the treatment recommendations for women with early-stage breast cancer. A recent report indicated that for most women
Researchers from Ottawa have found that a combination of a flu vaccine and erectile dysfunction drug was able to reduce the number of cancer metastases
Scientists have recently developed methods to detect breast cancer by measuring a patient’s breath and urine. They used electronic nose gas sensors for breath, along
Minimally invasive surgery (MIS) has proven benefits over “open surgery”: fewer complications, shorter hospitalization, lower rates of readmission and mortality, and lower health care costs. Unfortunately,
Vasalgel made the Daily Beast’s list of the medical advances in 2017 that “are going to not only dramatically transform how we think about the
If you or someone you know has adrenal insufficiency, you probably understand how difficult it is to regulate glucocorticoid replacement therapy. That’s because the body
Usually, the development of a medical device happens out of the public eye, but in our case, we have shared information with the public and
And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well: